Unbiased Analysis of Today's Healthcare Issues
The pharma industry’s reputation is getting worse. Pharmafile reports that “35.4% said that multinational pharma companies had either an ‘excellent’ or ‘good’ reputation in 2013. While this is about the same result as in 2012, it is well below 2011 when 41% of respondents gave that answer.” Below are the 2013 reputation rankings for different…
Maybe money can’t buy you love…but can it buy you influence over physician treatment choices? That’s what many pharmaceutical and medical device firms are betting on. Concerns about the influence of industry money have prompted universities [10] [10] such as Stanford and the University of Colorado-Denver to ban drug sales representatives from the halls of…